NEW YORK (GenomeWeb) – Nanosphere reported after the close of the market Wednesday preliminary fourth quarter revenue growth of 35 percent year over year.

The Northbrook, Ill.-based molecular diagnostics firm also said that it has received a warning letter from the US Food and Drug Administration related to deficiencies in the firm's quality system regulation.

For the quarter ended Dec. 31, Nanosphere reported preliminary revenues of $4.6 million, up from $3.4 million in the fourth quarter of 2014. Analysts, on average, expected revenues of $4.3 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.